TY - JOUR
TI - Trastuzumab deruxtecan for breast cancer
J2 - Aust Prescr
JF - Australian Prescriber
PY - 2022
ET - 2022/07/07
VL - 45
IS - 4
DO - 10.18773/austprescr.2022.043
LA - eng
UR - https://australianprescriber.tg.org.au/articles/trastuzumab-deruxtecan-for-breast-cancer.html
KW - breast cancer
KW - Enhertu
KW - trastuzumab deruxtecan
PB - Therapeutic Guidelines Ltd
SN - 1839-3942
ER -